NCT00881270

CompletedPhase 4

Dermacyd Infantile - Acceptability.

Sanofi Source

Compare

Other study identifiers

Sponsor study identifier

LACAC_L_04678

Study Type

interventional

Actual enrollment (reported)

31

Locations

1 country

Sites

1

Timeline

Study Start

March 2009

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

March 2009

Actual (reported)

Study Completion

March 2009

Actual (reported)

Brief Summary

Primary Objective: To prove the safety of the formulation in normal conditions of use.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 31 participants
Study completion date: March 2009
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
March 2009
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
March 2009
Actual (reported)
Study Completion
March 2009
Actual (reported)
First Submitted
April 10, 2009
Actual (reported)
First Posted
April 15, 2009
Actual (reported)

Last Updated: September 28, 2009
Status Verified: September 2009
Last Update Submitted: September 25, 2009

Conditions

Hygiene

Outcome Measures

Primary Outcomes (1)

The absence of irritation and the good acceptability will be evaluated using one specific scale which describes the intensity of the reaction.
From the treatment start to the end of the study

Study Arms (1)

Dermacyd infantile (Lactic Acid)

EXPERIMENTAL

treatment duration 21 consecutive days

Drug: LACTIC ACID(ND)

Interventions

LACTIC ACID(ND)Drug

Dermacyd Infantile (LACTIC ACID)

Dermacyd infantile (Lactic Acid)

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

AgeUp to 12 Years

Sexall

Healthy VolunteersYes

Age GroupsChild (0-17)

You may qualify if:

Integral skin test in the region
Use the same category of cosmetics

Sponsors & Collaborators

Sanofi
Industrylead

Study Sites (1)

Sanofi-Aventis Administrative Office

São Paulo, Brazil

Study Officials

Jaderson Lima
Sanofi
STUDY DIRECTOR

Enrollment

31 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: phase 4
Allocation: NON RANDOMIZED
Masking: NONE
Purpose: SUPPORTIVE CARE
Intervention Model: SINGLE GROUP
Sponsor Type: INDUSTRY

Study Record Dates

First Submitted

April 10, 2009

First Posted

April 15, 2009

Study Start

March 2009

Date type not reported

This date has not been verified as actual or estimated.

NCT00932945

Dermacyd PH_DESILSTY_FR (Lactic Acid) - Acceptability - Stay on Frutal

Phase 3Completed

NCT00933699

Dermacyd PH_DESILSTY_FL (Lactic Acid) - Acceptability - Stay on Floral.

Phase 3Completed

NCT00933842

Dermacyd PH_DESILSTY_FL (Lactic Acid) - Photo Evaluation - Stay on Floral

Phase 3Completed

NCT00933257

Dermacyd PH_DESILSTY_FR (Lactic Acid) - Photo Evaluation - Stay on Frutal

Phase 3Completed

NCT00932984

Dermacyd Silver Floral (Lactic Acid) - Photo Evaluation

Phase 3Completed

NCT00933075

Dermacyd Silver Frutal (Lactic Acid) - Photo Evaluation.

Phase 3Completed

Willingness in following the study procedures and to be present in the clinic at the days and scheduled time.

You may not qualify if:

Use of Anti-inflammatory, immunosuppressant or anti-histaminic drugs
Allergic or atopic history to cosmetics products
Cutaneous active disease (local or general) in the evaluated area
Disease which can cause immunosuppressant, such as diabetes, HIV
Endocrine pathology
Intensive solar exposure until 15 days before evaluation
Treatment four months before selection.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Contact the study team to confirm eligibility.

Primary Completion

March 2009

Actual (reported)

Study Completion

March 2009

Actual (reported)

Last Updated

September 28, 2009

Record last verified: 2009-09

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00881270
Data provider: ClinicalTrials.gov
Source updated: 2009-09-28
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:32:01 UTC

Locations

BR(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

Dermacyd infantile (Lactic Acid)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations